Primarily due to an unfriendly tariff environment, Chinese automaker BYD has suspended its consideration to enter the Canadian market to sell EVs and hybrids.
Nkarta’s pivot from oncology to autoimmune disease has continued with the biotech halting work on its CD19-directed CAR NK in lymphoma to focus on lupus. Seven patients with heavily pretreated large B ...